Siemens Awarded $1.78M FDA Contract to Showcase Advanced Digital Design and Manufacturing

• Siemens to install and configure an Advanced Digital Design and Manufacturing line as part of the FDA’s Advanced Manufacturing and Supply Chain programs to demonstrate how medical device manufacturers can leverage digital threads to derive virtual digital twins across the total product lifecycle, to accelerate product development, increase manufacturing capacity, and improve product quality

WHITE OAK, Md.–(BUSINESS WIRE)–The Food and Drug Administration’s (FDA) Office of Counterterrorism and Emerging Threats (OCET) has awarded a contract worth over $1.78M to Siemens Government Technologies (SGT) with technology from Siemens Digital Industries. Siemens will provide its expertise to implement advanced industrial software for digital design and an automated manufacturing production demonstration line for regulatory science use in the FDA OCET advanced manufacturing program. This program is collaborating with the Center for Devices and Radiological Health (CDRH) to provide FDA with access to extensive software from Siemens Digital Industries Software’s Xcelerator portfolio including advanced integrated software capabilities for design control and risk management; product lifecycle management; product, plant, and process design modeling and simulation; manufacturing execution; closed loop quality management; Industrial Internet of Things (IIoT), and much more.

The digital showcase will help facilitate evaluation, education and industry adoption of smart design and manufacturing processes, which can improve performance, speed regulatory review, reduce supply shortages and increase supply chain resilience in the Lifesciences industry.

“The FDA is focused on developing standards, metrics and data needs for the use of advanced digital design and manufacturing technologies,” said FDA Chief Scientist Rear Adm. Denise Hinton. “Furthering the adoption of these new technologies can help increase U.S. manufacturing capacity, increase supply chain resilience, decrease time to market for medical diagnostics, therapies and vaccines that are needed for public health emergency response.”

“We are excited to support the FDA as it evaluates applicable digital technologies for supply chain resilience in the face of great national challenges,” said Tina Dolph, president and CEO of Siemens Government Technologies. “Our supply chains are the true lifeblood of our ability to respond and adapt when facing a crisis, which is why the FDA’s work is so consequential.”

In addition to providing demonstrations of “the art of the possible” with advanced digitalization and factory automation, the showcase will help the FDA to gain an understanding of the different processes and technologies to help inform industry guidance, develop regulatory science tools and standards to evaluate incoming submissions, and prepare for potentially disruptive changes to design and production norms. This preparation and understanding aids in rapid responses to pandemics, such as the SARS-CoV-2 virus, and future emerging threats. This collaboration with Siemens, Carryline USA and Premier Automation will also include the commissioning of a conveyor system.

“Siemens is proud to support the FDA in the exploration of and experimentation with advanced digital capabilities that can be used to develop and manufacture life-saving products,” said Del Costy, Senior Vice President & Managing Director, Americas at Siemens Digital Industries.

“In addition to helping the FDA gain new perspectives in developing industry guidance, evaluation of submissions, and preparing for the next disruption; this technology showcase will also help demonstrate to manufacturers the possibilities that exist today to accelerate product development, improve performance, increase production capacity, and enable more flexible and agile manufacturing networks. With the FDA leading the way, this partnership will help accelerate the digital transformation occurring across the healthcare industry,” said Barbara Humpton, President and CEO of Siemens Corporation.

The contract between Siemens and the FDA will last for several years as new use cases are developed and implemented. Once the first set of use cases are live, the FDA may also host public events such as workshops. This project is funded by the FDA under contract but does not necessarily express the views or policies of the FDA.

For further information on the use of digital twins for advanced manufacturing, please visit https://www.sw.siemens.com/en-US/.

Siemens Government Technologies is the wholly-owned, cleared U.S. subsidiary of Siemens Corporation whose mission it is to secure and modernize the largest infrastructure in the world, the U.S. Federal Government. It does so by being the leading integrator of Siemens’ innovative products, technologies, software and services in the areas of digital engineering and modeling, efficient and resilient energy solutions, and smart infrastructure modernization.

Siemens Digital Industries Software is driving transformation to enable a digital enterprise where engineering, manufacturing and electronics design meet tomorrow. The Xcelerator portfolio helps companies of all sizes create and leverage digital twins that provide organizations with new insights, opportunities and levels of automation to drive innovation. For more information on Siemens Digital Industries Software products and services, visit www.sw.siemens.com or follow us on LinkedIn, Twitter, Facebook and Instagram. Siemens Digital Industries Software – Where today meets tomorrow.

Siemens Corporation is a U.S. subsidiary of Siemens AG, a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 170 years. Active around the world, the company focuses on intelligent infrastructure for buildings and distributed energy systems and on automation and digitalization in the process and manufacturing industries. Siemens brings together the digital and physical worlds to benefit customers and society. Through Mobility, a leading supplier of intelligent mobility solutions for rail and road transport, Siemens is helping to shape the world market for passenger and freight services. Via its majority stake in the publicly listed company Siemens Healthineers, Siemens is also a world-leading supplier of medical technology and digital health services. In addition, Siemens holds a minority stake in Siemens Energy, a global leader in the transmission and generation of electrical power that has been listed on the stock exchange since September 28, 2020. In fiscal 2020, Siemens Group USA generated revenue of $17 billion and employs approximately 40,000 people serving customers in all 50 states and Puerto Rico.

Note: A list of relevant Siemens trademarks can be found here. Other trademarks belong to their respective owners.

Contacts

Contact for journalists
Charlie DiPasquale

Phone: 240.481.6632; E-mail: Charlie.DiPasquale@siemens.com
Follow us on Twitter at: www.twitter.com/siemensUSA